LifeStance assumed with a Buy at Jefferies

Jefferies analyst Brian Tanquilut assumed coverage of LifeStance with a Buy rating and $7.25 price target. He is bullish on behavioral health and believe LifeStance’s behavioral model should be more resilient, said the analyst as he assumed coverage of a trio of outpatient consumer health names.